Research Peptides in Kazakhstan 2026: EAEU Rules, Import Tax, and Sourcing

# Research Peptides in Kazakhstan 2026: EAEU Rules, Import Tax, and Sourcing

Kazakhstan sits inside the Eurasian Economic Union's common pharmaceutical market, which means two layers of law apply to any peptide that crosses its border: the national Code on Public Health and the Healthcare System (Code No. 360-VI of 7 July 2020) and the union-level rules written by the Eurasian Economic Commission. Two things changed for importers at the start of 2026. The standard VAT rate rose from 12% to 16% under the new Tax Code (No. 214-VIII of 18 July 2025), and the EAEU's transition period for national medicine registrations ended on 31 December 2025. This guide explains where research-grade peptides fall under those rules, what a shipment actually costs to clear, and what the peptides.so listings data shows about supplier pricing for the compounds most often studied in the region.

For research purposes only. Everything described here concerns laboratory reagents for in vitro and preclinical study. Nothing on this page is a dosing, administration, or treatment recommendation.

Who regulates what

Four bodies matter for a research importer, and their responsibilities do not overlap as much as the names suggest.

• •Ministry of Health of the Republic of Kazakhstan sets policy and issues the orders that implement Code 360-VI, including the registration rules for medicines and medical devices (Order No. ҚР ДСМ-16 of 9 February 2021, amended by Order No. 146 of 18 November 2025).
• •Committee for Medical and Pharmaceutical Control, inside the Ministry, is the enforcement arm. It handles licensing of pharmaceutical activity, inspections, and the withdrawal of products that are sold as medicines without registration.
• •National Center for Expertise of Medicines and Medical Devices (NDDA) does the technical assessment behind registration and runs the public State Register at register.ndda.kz. If a product is not in that register, it is not a registered medicine in Kazakhstan. This is the fastest way to check the status of any peptide compound.
• •State Revenue Committee of the Ministry of Finance (kgd.gov.kz) is the customs and tax authority. The old "customs.kz" address that circulates in older guides is no longer where declarations, tariff lookups, or import VAT questions are handled.

Above all of them sits the Eurasian Economic Commission (EEC), whose Council Decision No. 78 of 3 November 2016 sets the union-wide rules for registering medicines. A 2025 review in Therapeutic Innovation and Regulatory Science describes the result as a two-pathway system, decentralised and mutual-recognition, modelled loosely on the European Union, but notes that the union "is still in its initial stages of full implementation" (PMID 40253511). A follow-up paper by the same group, "Comparative study of regulatory frameworks for medicinal products in Eurasian Economic Union and European Union" (PMID 41421546, Annales Pharmaceutiques Françaises, 2026), found the two frameworks similar in structure but divergent on timelines, labelling, clinical-trial process, and pharmacovigilance. For a researcher the practical consequence is that the paperwork a Russian or Belarusian supplier provides is often written against EAEU templates, which Kazakh customs and health officials recognise.

Where research peptides sit in the law

Code 360-VI regulates medicines, meaning products presented for the diagnosis, treatment, or prevention of disease in humans. A lyophilised peptide sold as a laboratory reagent, labelled "for research use only, not for human use", is not presented as a medicine and does not go through NDDA registration. That is the same distinction used in the EU and the United States, and it is why research peptides can be imported without a marketing authorisation.

A vendor who describes a peptide's effects on people, ships it with dosing instructions, or sells it through a pharmacy channel has presented it as a medicine, and at that point the Committee for Medical and Pharmaceutical Control can treat it as an unregistered medicine under the Code. Kazakh researchers should expect suppliers whose product pages read like drug advertising to be the ones most likely to have shipments stopped.

Two further checks apply to every compound, not to peptides as a class:

1. Controlled-substance status. Law No. 279-I of 10 July 1998 on narcotic drugs, psychotropic substances, their analogues and precursors, together with the control list approved by Government Decree No. 470 of 3 July 2019, governs scheduled compounds. The list is compound-specific. Check each peptide you intend to import against it rather than assuming that "peptides are not scheduled"; the list also captures analogues, and it is amended.

2. Registered-medicine status in the EAEU. Several peptides that circulate as research chemicals in North America and Western Europe are registered prescription medicines in Russia, most notably the ACTH(4-10) analogue Semax and the tuftsin analogue Selank. Within the union, a product registered in one member state can be recognised in another under the Decision 78 procedures. A Belgian official medicines control laboratory reported finding both compounds in seized preparations in 2017 and 2018, and noted that neither had completed clinical trials in the West even though both were freely sold online as lyophilised powder or nasal sprays (PMID 31667971). The same molecule can therefore be a registered medicine in Moscow, a research reagent in Almaty, and contraband in Brussels. Kazakh institutions buying Russian-manufactured Semax or Selank should decide up front whether they are importing a registered medicine (through a licensed pharmaceutical distributor) or a research reagent (through a chemical supplier), because the customs codes, VAT rate, and documentation differ.

What a shipment costs to clear in 2026

The figures below come from the new Tax Code and the State Revenue Committee's published customs rules. They apply to research reagents; registered medicines are taxed differently.

HS classification. The declared heading sets the duty rate, the documentary requirements, and whether the shipment is routed for pharmaceutical control. Synthetic peptides are commonly declared under heading 2937 (peptide hormones and their analogues) or 3504 (peptones and other protein substances), and some vendors use 3822 (diagnostic or laboratory reagents). Get a written classification from a licensed customs broker before the first order rather than relying on the code the supplier prints on the invoice.

Documentation to include. A commercial invoice stating "laboratory reagent, for research use only, not for human use"; a certificate of analysis with the HPLC purity and mass-spectrometry identity for the specific lot; a safety data sheet; and, for institutional buyers, a letter on university or institute letterhead stating the research purpose. Russian-language documents are accepted; some brokers recommend a Kazakh translation for institutional letters. Allow five to fourteen business days for clearance at Almaty or Astana, longer at land crossings.

Sourcing: what the platform data shows

peptides.so tracks live supplier listings rather than supplier claims. As of 20 September 2026 the platform holds 10,925 priced listings across 119 suppliers, of which 7,868 listings had a recorded price check in September. The platform does not record supplier shipping destinations, so we cannot say which vendors ship to Kazakhstan; use the figures below as a pricing baseline when comparing a quote from a regional distributor.

Prices are list prices in USD before shipping, duty, and the 16% import VAT; vial sizes are pooled because most supplier feeds do not pin the mg amount in the product name, so treat the median as an order-of-magnitude reference and compare quotes on a per-mg basis. A quote from a Russian or Belarusian distributor that lands well below these medians after the tariff advantage is plausible; one that lands well below them before any tariff advantage deserves a certificate of analysis request before payment.

Regional supply channels

• •EAEU manufacturers and distributors. Russia has a domestic peptide industry built around the Khavinson bioregulator line (Epitalon, Thymalin, and the short tissue-specific peptides) and the Semax and Selank medicines. Our Khavinson bioregulator guide covers the compound family; the Russia country guide covers Roszdravnadzor and Russian export paperwork. The duty-free advantage is real, but the 16% VAT applies regardless of origin.
• •Chinese and Indian custom-synthesis houses. The main source of bulk research peptide worldwide. Shipments arrive through the Khorgos and Dostyk crossings or by air to Almaty. Expect full duty at the EAEU tariff rate plus VAT.
• •US and EU research-chemical vendors. The majority of the 119 suppliers tracked on peptides.so. Most publish certificates of analysis on request; a minority publish them per lot. See our sourcing guides for Semax and Selank for the vendors that do.
• •Domestic institutions. Al-Farabi Kazakh National University (Almaty), Asfendiyarov Kazakh National Medical University (Almaty), Nazarbayev University (Astana), and the National Center for Biotechnology (Astana) are the institutions most likely to have HPLC and LC-MS facilities for verifying incoming material; confirm access with the relevant department. Buying through an institution also simplifies the customs letter.

Verifying what arrives

Two laboratory studies show how often the label and the vial disagree. Belgium's official medicines control laboratory built an LC-MS/MS screen for 25 peptides after repeated seizures of counterfeit and unregistered peptide preparations, and validated a companion UHPLC quantification method to ISO 17025 (PMID 26003685). A 2024 test-purchase study of semaglutide sold online without a prescription combined market surveillance with laboratory analysis of the products received and documented quality and safety failures across the sample (PMID 39509151). Neither study looked at Kazakh vendors specifically, and neither should be read as a purity statistic for the market as a whole; they show that the failure mode exists and that an HPLC purity figure on a supplier's website is not the same as a test on the lot in hand.

For Kazakh laboratories the practical sequence is: request the lot-specific certificate of analysis before ordering, confirm the certificate's HPLC and mass-spec values are for that lot number, and run an in-house identity check on receipt where the equipment exists. Our guides on reading a certificate of analysis and HPLC and mass-spectrometry purity testing explain what the numbers on a certificate mean and which ones vendors most often omit.

Frequently asked questions

Are research peptides legal to import into Kazakhstan?

Peptides sold and labelled as laboratory reagents are not medicines under Code 360-VI and do not require NDDA registration. They are subject to customs declaration, duty according to the HS heading, and 16% import VAT. Each compound should still be checked against the controlled-substances list under Law 279-I and Decree 470.

Does buying from Russia avoid tax?

It avoids customs duty, because goods in free circulation in an EAEU member move within the union without a tariff. It does not avoid VAT: from 1 January 2026 imports from EAEU territory are subject to 16% VAT, paid to the State Revenue Committee.

Is Semax or Selank a registered medicine in Kazakhstan?

Check register.ndda.kz for the current answer; registration status changes and the register is the authoritative source. Both are registered medicines in Russia. If you import them as medicines they follow the pharmaceutical channel; if you import them as research reagents, the vendor must present them as reagents and you must declare them as such.

Which HS code should I use?

There is no single correct answer for "peptides". Headings 2937, 3504, and 3822 are all in use depending on the compound and its presentation. A written classification ruling from a licensed broker, or a preliminary decision from the State Revenue Committee (fee: 9 MCI), protects you at inspection.

What changed on 1 January 2026?

The standard VAT rate rose from 12% to 16%, the VAT registration threshold halved to 10,000 MCI, and the EAEU's transition period for purely national medicine registrations ended on 31 December 2025, so medicines now have to be registered or re-registered under the union rules.

Can I rely on the supplier's certificate of analysis?

Treat it as a starting point. Published test-purchase studies have found products that did not match their labels. A lot-specific certificate is necessary; an in-house identity check on receipt is the only way to know what is in the vial you have.

Related reading

• •Research peptide regulatory landscape: a cross-jurisdiction overview
• •Research peptides in Russia 2026
• •Research peptides in Ukraine 2026
• •Research peptides in Turkey 2026
• •How to read a peptide certificate of analysis

References

1. Keerthana CP, Sharma S. Navigating the Evolving Eurasian Economic Union's Pharmaceutical Landscape: Streamlining Drug Registration for Market Access. Ther Innov Regul Sci. 2025;59(4):693-706. PMID 40253511

2. Cp K, Sharma S. Comparative study of regulatory frameworks for medicinal products in Eurasian Economic Union and European Union. Ann Pharm Fr. 2026;84(3):442-453. PMID 41421546

3. Vanhee C, Francotte A, Janvier S, Deconinck E. The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind. Drug Test Anal. 2020;12(3):371-381. PMID 31667971

4. Vanhee C, Janvier S, Desmedt B, et al. Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies. Talanta. 2015;142:1-10. PMID 26003685

5. Ashraf AR, Mackey TK, Vida RG, et al. Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res. 2024;26:e65440. PMID 39509151

Regulatory sources: Code of the Republic of Kazakhstan No. 360-VI "On Public Health and the Healthcare System" (adilet.zan.kz/eng/docs/K2000000360); Tax Code No. 214-VIII of 18 July 2025; Law No. 279-I of 10 July 1998 and Government Decree No. 470 of 3 July 2019 (adilet.zan.kz); EEC Council Decision No. 78 of 3 November 2016 as amended by Decision No. 34 of 22 May 2025; State Revenue Committee customs guidance (kgd.gov.kz); NDDA State Register (register.ndda.kz).

---

Research Use Only disclaimer. The peptides discussed on this page are laboratory reagents intended for in vitro and preclinical research. They are not approved for human or veterinary use in Kazakhstan or the EAEU as research products, and nothing here constitutes medical, legal, or customs advice. Tax rates, tariff schedules, and control lists change; confirm the current position with the State Revenue Committee, the NDDA register, and a licensed customs broker before importing.

Last reviewed: 20 September 2026.